Kevin Forsyth
Nurse Practitioner · Georgetown, DENPI 1598543142
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,896 and has fallen 65.7% since, to $994 in 2025. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$638
- AstraZeneca$509
- Pfizer$347
- Ardelyx, Inc.$227
- Exact Sciences$206
- Bayer$206
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $638 |
| AstraZeneca(2 entities) | 21 | $509 |
| Pfizer | 18 | $347 |
| Ardelyx, Inc. | 5 | $227 |
| Exact Sciences | 8 | $206 |
| Bayer | 12 | $206 |
| Lilly USA, LLC | 9 | $199 |
| GSK | 10 | $186 |
| Sumitomo Pharma America, Inc. | 9 | $178 |
| Corcept Therapeutics | 6 | $173 |
| Shield Therapeutics Inc | 3 | $162 |
| Astellas Pharma US Inc | 7 | $147 |
| Novo Nordisk | 7 | $136 |
| Esperion Therapeutics, Inc. | 6 | $107 |
| Phathom Pharmaceuticals, Inc. | 6 | $97 |
| Johnson & Johnson | 4 | $96 |
| Boehringer Ingelheim | 4 | $81 |
| Merck | 3 | $81 |
| Eisai Inc. | 3 | $77 |
| Novartis | 4 | $76 |
| Dexcom, Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Lundbeck LLC | 3 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Gilead | 2 | $51 |
| Amgen | 2 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Vertos Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,365 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $48,323 |
| Ipratropium Bromide | 40 | $1,440 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $571 |
| Rosuvastatin Calcium | 28 | $499 |
| Amlodipine Besylate | 44 | $396 |
| Losartan Potassium | 25 | $367 |
| Tizanidine Hcl | 26 | $352 |
| Atorvastatin Calcium | 23 | $253 |
| Omeprazole | 17 | $196 |
| Zolpidem Tartrate | 12 | $182 |
| Gabapentin | 11 | $162 |
| Alprazolam | 14 | $143 |
| Mupirocin | 14 | $129 |
| Tramadol Hcl | 19 | $123 |
| Levothyroxine Sodium | 14 | $120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $136 | $48,32319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 487 nurse practitioner providers in Delaware.
Other nurse practitioner in Georgetown
- Logan FordGeorgetown$4K
- Leena SajGeorgetown$4K
- Melissa GallowayGeorgetown$3K
- Meghan McCarterSeaford$170K
- Chandni PatelMiddletown$113K
- Craig LaingMilford$51K
- Colleen DitroWilmington$16K
- Sedelle Henderson-BamideleNewark$13K
- Jennifer HubbardWilmington$12K
- Kathleen HudsonMillville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.